These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 29501944)

  • 1. Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.
    Ruiz-Santaquiteria M; de Castro S; Toro MA; de Lucio H; Gutiérrez KJ; Sánchez-Murcia PA; Jiménez MÁ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2018 Apr; 149():238-247. PubMed ID: 29501944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity
    Ruiz-Santaquiteria M; Sánchez-Murcia PA; Toro MA; de Lucio H; Gutiérrez KJ; de Castro S; Carneiro FAC; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2017 Jul; 135():49-59. PubMed ID: 28431354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides.
    de Lucio H; Gamo AM; Ruiz-Santaquiteria M; de Castro S; Sánchez-Murcia PA; Toro MA; Gutiérrez KJ; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    Eur J Med Chem; 2017 Nov; 140():615-623. PubMed ID: 29017116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase.
    Revuelto A; Ruiz-Santaquiteria M; de Lucio H; Gamo A; Carriles AA; Gutiérrez KJ; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    ACS Infect Dis; 2019 Jun; 5(6):873-891. PubMed ID: 30983322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridazino-pyrrolo-quinoxalinium salts as highly potent and selective leishmanicidal agents targeting trypanothione reductase.
    de Lucio H; García-Marín J; Sánchez-Alonso P; García-Soriano JC; Toro MÁ; Vaquero JJ; Gago F; Alajarín R; Jiménez-Ruiz A
    Eur J Med Chem; 2022 Jan; 227():113915. PubMed ID: 34695777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates.
    Garnica P; Etxebeste-Mitxeltorena M; Plano D; Moreno E; Espuelas S; Antonio Palop J; Jiménez-Ruiz A; Sanmartín C
    Bioorg Med Chem Lett; 2020 Sep; 30(17):127371. PubMed ID: 32738977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides.
    Toro MA; Sánchez-Murcia PA; Moreno D; Ruiz-Santaquiteria M; Alzate JF; Negri A; Camarasa MJ; Gago F; Velázquez S; Jiménez-Ruiz A
    Chembiochem; 2013 Jul; 14(10):1212-7. PubMed ID: 23744811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
    Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
    Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents.
    Baquedano Y; Alcolea V; Toro MÁ; Gutiérrez KJ; Nguewa P; Font M; Moreno E; Espuelas S; Jiménez-Ruiz A; Palop JA; Plano D; Sanmartín C
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3802-12. PubMed ID: 27067328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient Dimerization Disruption of
    Revuelto A; de Lucio H; García-Soriano JC; Sánchez-Murcia PA; Gago F; Jiménez-Ruiz A; Camarasa MJ; Velázquez S
    J Med Chem; 2021 May; 64(9):6137-6160. PubMed ID: 33945281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism underlying antileishmanial effect of oxabicyclo[3.3.1]nonanones: inhibition of key redox enzymes of the pathogen.
    Saudagar P; Saha P; Saikia AK; Dubey VK
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):569-77. PubMed ID: 24002022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
    Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
    Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small Molecule-Peptide Conjugates as Dimerization Inhibitors of
    Revuelto A; López-Martín I; de Lucio H; García-Soriano JC; Zanda N; de Castro S; Gago F; Jiménez-Ruiz A; Velázquez S; Camarasa MJ
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gold-containing drug against parasitic polyamine metabolism: the X-ray structure of trypanothione reductase from Leishmania infantum in complex with auranofin reveals a dual mechanism of enzyme inhibition.
    Ilari A; Baiocco P; Messori L; Fiorillo A; Boffi A; Gramiccia M; Di Muccio T; Colotti G
    Amino Acids; 2012 Feb; 42(2-3):803-11. PubMed ID: 21833767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Leishmania infantum trypanothione reductase by diaryl sulfide derivatives.
    Saccoliti F; Angiulli G; Pupo G; Pescatori L; Madia VN; Messore A; Colotti G; Fiorillo A; Scipione L; Gramiccia M; Di Muccio T; Di Santo R; Costi R; Ilari A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):304-310. PubMed ID: 28098499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity.
    de Lucio H; Revuelto A; Carriles AA; de Castro S; García-González S; García-Soriano JC; Alcón-Calderón M; Sánchez-Murcia PA; Hermoso JA; Gago F; Camarasa MJ; Jiménez-Ruiz A; Velázquez S
    Eur J Med Chem; 2022 Dec; 244():114878. PubMed ID: 36332553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical and folding parameters of trypanothione reductase from Leishmania infantum.
    Shukla AK; Patra S; Dubey VK
    Appl Biochem Biotechnol; 2011 Sep; 165(1):13-23. PubMed ID: 21445596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae).
    Lima GS; Castro-Pinto DB; Machado GC; Maciel MA; Echevarria A
    Phytomedicine; 2015 Nov; 22(12):1133-7. PubMed ID: 26547537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
    Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
    ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.